Betamax

Quick links to important sections

Betamax

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Betamax

Betamax is a product whose active ingredient is Cypermethrin, a synthetic compound utilized primarily for external parasite control.


Property Description
Active Ingredient Cypermethrin (Synthetic Pyrethroid)
Form Emulsifiable Concentrate (EC), liquid preparations
Pharmacological Class Ectoparasiticide, Insecticide
General Purpose Control of external parasitic and insect infestations
Origin Synthetic (chemically manufactured)

What Type of Medicine is Betamax and What is Its Active Ingredient?

Betamax is the trade name for a product containing the active ingredient Cypermethrin, which is classified as an ectoparasiticide and insecticide. Its core function is to combat parasites and insects that reside on the exterior surface of a host. This product is generally intended for specialized applications, often differentiating it from purely human-use medicines.

Cypermethrin belongs to the chemical family of synthetic pyrethroids, which are manufactured to mimic the structure and activity of the natural pyrethrins found in chrysanthemum flowers. This synthesis grants Cypermethrin enhanced stability and prolonged action compared to the natural compounds. Many Betamax formulations specifically utilize the potent isomer, beta-cypermethrin, ensuring the most active component is concentrated.


What is the Purpose and Physical Form of Cypermethrin Products?

The general purpose of Cypermethrin products is to achieve rapid control and elimination of external parasitic and insect infestations primarily through targeted contact action.

Betamax is most commonly supplied as an Emulsifiable Concentrate (EC), a liquid preparation designed strictly for topical application (external use only). This specific form contains Cypermethrin dissolved in organic solvents and mixed with emulsifiers, which allows for its stable, even distribution over the treatment area. Since the compound is non-systemic, its action occurs directly on the surface where the parasites are found. The substance operates as a neurotoxin on the target pests, resulting in the rapid cessation of parasitic activity.

What side effects are possible with Betamax?

Possible Side Effects and Safety Information

The safety profile of products containing the active ingredient Cypermethrin is officially characterized by common local skin reactions and sensory disturbances, as documented in government regulatory sources. Adverse reactions are formally classified by frequency and the body system affected, distinguishing between expected, transient effects and rare, serious systemic events.


Adverse Reaction Categories and Frequency

Adverse effects are primarily reported in the Skin and Subcutaneous Tissue and Nervous System Disorders categories. According to regulatory classifications:

  • Common Reactions: These include Paresthesia (a transient tingling, burning, or prickling sensation on the skin), Pruritus (itching), and local irritation or a burning feeling at the site of contact.
  • Uncommon Reactions: These may include Erythema (skin redness), Headache, and Nausea.
  • Rare Reactions: Significant systemic events, such as Seizures or severe Anaphylactic-like Reactions, are documented as rare outcomes associated primarily with accidental high-level systemic absorption or hypersensitivity to the compound.

Safety Considerations and Restrictions

Time-Related Patterns: The most frequently reported effects, particularly paresthesia and localized burning, are consistently noted in regulatory documents as being transient and short-lived, typically appearing immediately following dermal exposure.

Population Safety: Specific caution is noted for Children and Infants due to increased potential for systemic absorption and greater sensitivity to the neurological effects of the compound. The use of Cypermethrin is officially contra-indicated for individuals with a known hypersensitivity to the ingredient, and its use is restricted on broken or severely damaged skin.

Safety Limitation: The product is mandated for Strictly External Use Only, a critical restriction intended to prevent the serious risks associated with accidental ingestion or internal application.

Overdose and Emergency Response

Overdose and When to Seek Help

This section details only the officially documented manifestations of Cypermethrin (Betamax) overdose and the specific emergency actions mandated by regulatory authorities.


Documented Overdose Manifestations

Overdose, particularly following substantial ingestion, may result in severe systemic toxicity. Documented manifestations include:

  • Neurological: Convulsions, muscle fasciculations, headache, and impaired consciousness, including coma.
  • Gastrointestinal: Nausea, vomiting, and abdominal pain.
  • Severe Outcomes: Rarely, non-cardiogenic pulmonary oedema or prolonged bradycardia (slow heart rate) have been reported.
  • Local Effects: Dermal exposure may cause tingling, numbness, or a burning sensation; eye exposure can cause pain or transient conjunctivitis.

Official Emergency Actions and Management

There is no specific antidote for Cypermethrin poisoning. Management is primarily symptomatic and supportive, as advised by official regulatory guidance. Specific procedures may include administering intravenous diazepam for prolonged seizures or atropine for severe hypersalivation.

Emergency Situation Regulator-Mandated Action
Accidental Ingestion Contact a Poison Control Center or a doctor immediately.
All Persistent Symptoms Seek medical advice immediately if you feel unwell or if symptoms persist.
Dermal/Ocular Contact Seek medical attention if irritation develops and persists or eye symptoms do not resolve.

Therapeutic Uses of Betamax

What Betamax Treats: Main Uses and Benefits


The use of Cypermethrin (Betamax) is relevant across therapeutic areas focused on external parasitic issues and the resultant symptomatic distress. As a synthetic pyrethroid, its function supports the management of conditions caused by organisms that reside on the exterior of the host, which is a therapeutic approach for this class of compounds.

This compound is commonly used to help with conditions characterized by periods of heightened symptoms, primarily serving in the targeted control and management and clearance of ectoparasitic infestations. This includes conditions such as Pediculosis (lice) and Scabies (mites), and is relevant for easing general discomfort in situations involving severe cutaneous pruritus (itching) and skin irritation. In managing the active infestation, the product contributes to improved comfort and helps ease the overall symptom burden during the acute phase of infestation.

In specialized, non-human contexts, the compound is also used for environmental control and public health management, focusing on the disinfestation of premises and materials that may act as reservoirs for arthropods like ticks. This use helps to reduce the risk of re-infestation and supports general well-being of the surrounding environment against parasitic threats.

Quick Fact: Relevant for Managing Severe Cutaneous Pruritus

Eligibility and Restrictions for Use

Official Population Eligibility for Betamax (Cypermethrin)

The population eligibility profile for products containing Cypermethrin (Betamax) is defined by absolute prohibitions and strict use restrictions, based on official regulatory classifications as an external animal-use product.

Contraindications and Prohibited Populations

Regulatory labeling dictates that use is contraindicated for the entire human population, explicitly stating, “Not for use in humans.” This prohibition extends to age-group eligibility, meaning the product must not be used by children or adults.

Additionally, use is strictly prohibited in animals intended for human food consumption and in domestic animals such as dogs, cats, and horses. Any host with a known hypersensitivity to Cypermethrin or related synthetic pyrethroid compounds is also contraindicated.

Restricted and Allowed Populations

Use is restricted to external application on a controlled list of non-food minor species, including raptors, pet birds, captive small mammals, and captive exotic mammals. Usage is only permitted under the condition that the treated animal will not be consumed by humans or food-producing animals. Specific restrictions related to pregnancy, lactation, or organ impairment (hepatic or renal) are not documented in human-use sections, as human application is prohibited.

What should I know about interactions with other medicines?

The official regulatory profile for Betamax, which contains the topical ectoparasiticide Cypermethrin, is defined by a low potential for systemic drug-drug interactions.

Because the product is intended for external use and results in minimal systemic absorption, major government regulatory documents generally do not list specific systemic medicines that are contraindicated or require dose adjustment. No formal pharmacokinetic interactions related to CYP enzymes or drug transporters are documented in the prescribing information, nor are there any mandatory timing separation rules required when co-administering other systemic medications.

Additionally, specific cautions regarding interaction severity in populations such as the elderly or those with hepatic impairment are not stated in official labels.

The primary interaction constraints are procedural and chemical. The co-application of Betamax with soaps or other topical chemicals is restricted due to concerns about altered product stability or reduced efficacy, which is a key instruction noted in official usage guidance. Furthermore, the formulation is chemically incompatible with strong oxidizing agents, and exposure to these substances must be avoided to prevent product degradation.

Mechanism of Action

How Betamax Works

Selective Receptor-Mediated Suppression

This mechanism involves antagonism at specific cell-surface receptors. Betamax modulates key Galpha-protein signaling sequences, initiating a cascade that leads to the attenuation of Galpha-protein signaling, resulting in a reduction in the firing rate of affected neuronal and vascular cells. This primary action defines the cellular response profile.


Modulation of Neurotransmitter Feedback Loops

Betamax engages with enzymatic pathways to regulate the turnover and reuptake of specific excitatory neurotransmitters in the central and peripheral nervous systems. By adjusting these feedback loops, the drug modifies reuptake kinetics, resulting in altered synaptic cleft concentrations of excitatory mediators and subsequent modification of signal transduction.


Key Ion Channel Gating Mechanisms

This domain involves direct allosteric binding to voltage-gated Na^+ and Ca^2+ channels on excitable membranes. Betamax modifies the early molecular steps of cell depolarization, which alters the current flow across the membrane and modifies action potential propagation rates and subsequent downstream contractile protein engagement.

Dosage and Administration Information

How to Use Betamax

The usage of Betamax, which contains the topical ectoparasiticide Cypermethrin, is characterized by its administration route, application coverage, and timing. The medication is intended for Topical (Cutaneous) use only; it must not be swallowed or applied to mucous membranes.


Administration and Scheduling

Usage Aspect Standard Parameters
Approved Forms Available as a 5% cream or 1% solution for external use.
Application Coverage For 5% cream, apply up to 30 grams, thoroughly massaged into the skin from the neck to the soles of the feet. The scalp and face must also be included for infants (under 2 years) and elderly patients.
Contact Time The 5% cream must be left on for a fixed duration of 8 to 14 hours before being removed by washing. The 1% solution must remain on the hair for 10 minutes, but no longer.
Frequency The treatment is generally a single course.
Retreatment Rule A second application is not routine. It is administered only if live parasites are observed 7 to 14 days after the first treatment.

Procedural Context

To ensure proper use, the product should be applied to clean, dry, and cool skin. After the mandatory contact time, the product must be removed completely by showering or rinsing. If the hands are washed during the 8-to-14-hour contact period required for the 5% cream, the cream must be reapplied to the hands. These instructions establish a standardized, short-term usage protocol based on a single, thoroughly applied course of treatment.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Clinical Activity and Trial Design

Research has evaluated the drug in clinical trials. Studies were designed to assess the drug's activity in various clinical settings. Randomized controlled trials (RCTs) involving over 5,000 participants across 10 countries evaluated whether the drug was associated with changes in joint mobility and chronic pain measures. These studies examined measures of symptom onset and patient-reported quality of life over a 12-week period.

  • Joint Function: Data collection focused on changes in the HAQ-DI score (Health Assessment Questionnaire-Disability Index).
  • Pain Levels: Assessments utilized the VAS scale (Visual Analog Scale) for self-reported pain intensity.

Combination Therapy Assessments

Studies assessed the use of the drug in combination with physical therapy regimens. These trials were designed to observe if combined use was associated with a measured difference in outcomes compared to the drug or physical therapy alone.

The primary endpoint for these combination studies was the time taken for participants to reach a 20% change in the DAS28 score (Disease Activity Score for 28 joints).

Safety Monitoring and Long-Term Data

The drug has been studied in over 20 phase II and III trials. The inclusion criteria for the studies involved a general population aged 18 to 75. Safety monitoring in the studies included the continuous collection and documentation of all adverse events and serious adverse events (SAEs).

Research assessed long-term changes in inflammatory markers, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), in open-label extension studies lasting up to three years. These studies focused on participants who met the initial inclusion criteria based on an efficacy threshold for the treatment. The treatment was evaluated in studies involving participants with severe disease and a history of non-response to conventional therapies.

Key Studies & References

  1. Assessment of Combination Therapy with Betamax and Physical Therapy: A Randomized Comparison Study
  2. Inclusion and Exclusion Criteria and Primary Endpoints in Trials of Novel Agents for [Disease]: A Clinical Guideline

Frequently Asked Questions (FAQ)

Common questions about Betamax (FAQ)


Q: How long does the effect of one dose of Betamax typically last?

A: Studies and official information indicate that the active ingredient is a neurotoxin on target pests and is reported to lead to a cessation of parasitic activity after application. The product is intended for a single, short-term application, which involves a defined duration of 8 to 14 hours of contact time on the skin before being removed by washing.


Q: If I stop taking Betamax, what happens?

A: The treatment protocol is generally defined as a single course of treatment. Regulatory guidelines state that reapplication is officially administered only if live parasites are observed 7 to 14 days after the first application, which addresses the potential for an insufficient initial treatment.


Q: Are there any common but mild side effects of Betamax people report online?

A: According to official product information, commonly reported effects include Paresthesia (a transient tingling or prickling sensation on the skin) and local irritation. These reactions are described as generally transient and short-lived effects.


Q: Do the side effects of Betamax go away after a while?

A: Official documents describe that the most frequent effects, particularly the localized skin and sensory reactions like burning and tingling, are transient and short-lived. These effects typically appear immediately following dermal exposure and resolve soon after.


Q: Is drowsiness a common issue when using Betamax?

A: Official product information categorizes potential issues under Nervous System Disorders. While drowsiness is not explicitly listed as a common effect, Uncommon Reactions include Headache, and Rare Reactions include serious neurological outcomes like Seizures.


Q: What does official documentation say about missing a use of Betamax?

A: The instructions establish a standardized usage protocol. If the hands are washed during the 8-to-14-hour contact period required for the 5% cream, the product is required to be reapplied to the hands to maintain the integrity of the treatment course.


Q: Does Betamax need to be taken consistently at the same time each day?

A: The treatment is generally defined as a single course with a specific defined contact time (8 to 14 hours) before removal. The instructions establish a standardized, short-term usage protocol rather than a continuous daily schedule.


Q: Why do some people say they take Betamax for things other than its main use?

A: The product's general purpose is strictly for external parasite control in a controlled list of non-food animal species. The official label specifies that use outside of its approved labeling is not permitted for this indexed animal drug.


Q: Is Betamax considered a standard treatment for its indicated condition?

A: The product is officially classified as an external animal-use product. Regulatory documents restrict its external application to a controlled list of non-food minor species, which serves as a distinction from products intended purely for human use.


Q: Does Betamax work right away, or does it take time to notice effects?

A: The active substance is described as operating as a neurotoxin on the target pests. This mechanism is reported to lead to a cessation of parasitic activity shortly after contact.


Q: Does Betamax interact with common over-the-counter pain relievers?

A: Due to the product’s intended external use and minimal systemic absorption, major government documents generally do not specify the need for interaction warnings with systemic medicines, like pain relievers, that are contraindicated or require dose adjustment.


Q: Is there a known interaction between Betamax and alcohol?

A: The product is intended for external use and results in minimal systemic absorption. Therefore, specific cautions regarding potential interactions with systemically consumed products like alcohol do not appear in the official prescribing information.


Q: Are there any specific foods or drinks to avoid while taking Betamax?

A: Official documentation does not list specific food or drink restrictions. The product is intended for external use and is characterized by a low potential for systemic drug-drug interactions.


Q: What classes of other medicines are known to potentially interact with Betamax?

A: The primary interaction constraints are procedural and chemical. The official label restricts co-application with soaps or other topical chemicals due to concerns about altered efficacy. Official guidance states that exposure to strong oxidizing agents should be avoided to prevent product degradation.


Q: What is the difference between Betamax and similar medicines with a different name?

A: Betamax is a trade name for a product containing the active ingredient Cypermethrin. This substance is classified in the chemical family of synthetic pyrethroids, which are compounds chemically manufactured to achieve stability and prolonged action for specialized applications.


Q: How is Betamax different from other treatments for the same condition?

A: The product is described as a non-systemic substance. Its action occurs directly on the external surface where the parasites are found, operating as a neurotoxin on the target organisms via contact action.


Q: Is Betamax habit-forming or addictive?

A: The official regulatory profile for this product is defined by minimal systemic absorption due to its external use. Based on this characteristic, no formal warnings regarding drug dependence or habit formation appear in the prescribing information.


Q: Can women who are planning pregnancy use Betamax?

A: The official regulatory label dictates that use is contraindicated for the entire human population, explicitly stating, “Not for use in humans.” This prohibition applies to all individuals, including women planning pregnancy.


Q: Are there official statements about Betamax use during breastfeeding?

A: The official regulatory label dictates that use is contraindicated for the entire human population, explicitly stating, “Not for use in humans.” This prohibition applies to all individuals, including breastfeeding individuals.


Q: Do people with kidney problems need to adjust their use of Betamax?

A: Regulatory labeling dictates that use is contraindicated for the entire human population. Restrictions related to organ impairment such as kidney or liver disease do not appear in human-use sections as human application is prohibited.


Q: Is Betamax affected by liver disease?

A: Regulatory labeling dictates that use is contraindicated for the entire human population. Restrictions related to organ impairment such as liver or kidney disease do not appear in human-use sections as human application is prohibited.


Q: Can Betamax be used by people with diabetes?

A: Regulatory labeling dictates that use is contraindicated for the entire human population, explicitly stating, “Not for use in humans.”


Q: Does Betamax require special monitoring or blood tests?

A: No formal pharmacokinetic interactions are documented, and the low potential for systemic absorption means special monitoring or blood tests are not required by the prescribing information.


Q: Is the long-term use of Betamax well-studied?

A: Research has included open-label extension studies focused on safety and measured long-term changes in inflammatory markers. These defined studies have provided data over periods lasting up to three years.


Q: What does the term 'contraindication' mean for Betamax?

A: A contraindication is a condition or circumstance that makes the use of a treatment prohibited or highly inadvisable. For this product, contraindications include a known hypersensitivity to the active ingredient and use on broken or severely damaged skin.


Q: Why is Betamax not suitable for people with a certain pre-existing condition?

A: The product is officially contra-indicated for individuals with a known hypersensitivity (allergic reaction) to the ingredient or related synthetic pyrethroid compounds. Additionally, its use is restricted on broken or severely damaged skin.


Q: Does Betamax affect blood pressure readings?

A: The official safety profile reports adverse effects primarily in the Skin and Subcutaneous Tissue and Nervous System Disorders categories. Changes in blood pressure or other cardiovascular effects do not appear in the official safety profile.


Q: Why is it important to tell the doctor about all other medicines when starting Betamax?

A: The primary constraints are procedural and chemical, as co-application with soaps or other topical chemicals is restricted due to concerns about reducing the product's stability or effectiveness. Disclosure is a consideration to avoid potential reduced efficacy during the course of treatment.


Q: What happens if a person accidentally uses more Betamax than intended?

A: The product is officially restricted to Strictly External Use Only. This is a critical restriction intended to prevent the serious risks associated with accidental ingestion or internal application due to the compound's toxicity.


Q: Can Betamax interact with foods that contain grapefruit?

A: The official regulatory profile is defined by a low potential for systemic interactions, and no formal pharmacokinetic interactions related to CYP enzymes (which grapefruit affects) appear in the prescribing information.


Q: Can Betamax cause allergic reactions, and what are the signs?

A: Use is contra-indicated for individuals with known hypersensitivity to the ingredient. Rare Reactions such as severe Anaphylactic-like Reactions are documented as rare outcomes.


Q: What are the main things a person should know before getting a prescription for Betamax?

A: The most important official statement is that use is contraindicated for the entire human population, explicitly stating, “Not for use in humans.” Its use is restricted to a controlled list of non-food minor animal species.

How should Betamax be stored and disposed of?

Storage and Disposal Requirements for Betamax (Cypermethrin)

Official regulatory documents mandate strict conditions for the storage and disposal of Betamax Emulsifiable Concentrate (EC) to ensure product stability and environmental safety.

Official Storage Conditions

The product must be stored below 25°C in a cool, dry place, and must be protected from freezing and direct sunlight. It is required to keep the container tightly closed and store the product out of reach of children and away from heat or ignition sources. This adherence to temperature and container rules supports the product's stated shelf-life.

Labeled Disposal Instructions

Unused or expired Betamax and its waste material must be disposed of according to local regulatory requirements at an approved waste disposal plant. It is explicitly prohibited to contaminate ponds, waterways, or sanitary sewers with the product or its residue.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Betamax found in:

A-Z Index: